US 11045558
RPGR gene therapy for retinitis pigmentosa
granted A61KA61K48/005A61K9/0048
Quick answer
US patent 11045558 (RPGR gene therapy for retinitis pigmentosa) held by The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K48/005, A61K9/0048, A61P, A61P27/02